A machine learning tool that analyzes voice recordings collected by telephone can accurately identify people with Parkinson’s disease, scientists…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
In a new policy paper, the Movement Disorders Policy Coalition — an advocacy group for people living with movement…
People with Parkinson’s disease who are given deep brain stimulation (DBS) tend to have more stable long-term life quality…
The virus that causes COVID-19 is able to infect dopamine-producing brain cells and trigger a specific pattern of dysfunction that…
Risvodetinib, an experimental therapy that Inhibikase Therapeutics is developing for Parkinson’s disease, was well tolerated both by healthy…
Being a caregiver for someone with Parkinson’s disease can be difficult, but for family members, providing care is…
A new study by scientists in Australia may be set to overturn more than a decade of thinking that the…
Scientists have proposed a new way to classify Parkinson’s disease based on biological changes associated with the disorder. “Without…
ProMIS Neurosciences announced arriving at a lead candidate vaccine against the misfolded alpha-synuclein protein, which the company plans…
Air pollution may increase the risk of Parkinson’s disease, particularly in people who are already genetically predisposed to develop…